Advertisement
Screener

PERSPECTIVE THERAPEUTICS, INC. (CATX) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

PERSPECTIVE THERAPEUTICS, INC. Shares Authorized

PERSPECTIVE THERAPEUTICS, INC. (CATX) had Shares Authorized of 750.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-10

  • 2026-06-30: Common Stock, Shares Authorized 750.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 750.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 750.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 750.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30750.00M shares
10-Q · filed 2026-08-10
2026-03-31750.00M shares
10-Q · filed 2026-05-11
2025-12-31750.00M shares
10-Q · filed 2026-08-10
2025-09-30750.00M shares
10-Q · filed 2025-11-10
2025-06-30750.00M shares
10-Q · filed 2025-08-13
2025-03-31750.00M shares
10-Q · filed 2025-05-12
2024-12-31750.00M shares
10-K · filed 2026-03-16
2024-09-30750.00M shares
10-Q · filed 2024-11-12
2024-06-30750.00M shares
10-Q · filed 2024-08-13
2024-03-31750.00M shares
10-Q · filed 2024-05-15
2023-12-31750.00M shares
10-K/A · filed 2025-03-28
2023-09-30750.00M shares
10-Q · filed 2023-11-14
2023-06-30750.00M shares
10-Q · filed 2023-08-11
2023-03-31750.00M shares
10-Q · filed 2023-05-15
2022-12-31750.00M shares
10-K · filed 2024-03-28
200.00M shares
10-KT · filed 2023-05-01
2022-09-30200.00M shares
10-Q · filed 2022-11-14
2022-06-30200.00M shares
10-KT · filed 2023-05-01
2022-03-31200.00M shares
10-Q · filed 2022-05-13
2021-12-31200.00M shares
10-Q · filed 2022-02-09
2021-09-30200.00M shares
10-Q · filed 2021-11-10
2021-06-30200.00M shares
10-KT · filed 2023-05-01
2021-03-31200.00M shares
10-Q · filed 2021-05-14
2020-12-31200.00M shares
10-Q · filed 2021-02-09
2020-09-30200.00M shares
10-Q · filed 2020-11-13
2020-06-30200.00M shares
10-K · filed 2021-09-27
2020-03-31200.00M shares
10-Q · filed 2020-05-13
2019-12-31200.00M shares
10-Q · filed 2020-02-12
2019-09-30200.00M shares
10-Q · filed 2019-11-13
2019-06-30200.00M shares
10-K · filed 2020-09-25
2019-03-31200.00M shares
10-Q · filed 2019-05-10
2018-12-31200.00M shares
10-Q · filed 2019-02-13
2018-09-30193.00M shares
10-Q · filed 2018-11-09
2018-06-30200.00M shares
10-K · filed 2019-09-27
193.00M shares
10-K · filed 2018-09-26
2018-03-31193.00M shares
10-Q · filed 2018-05-04
2017-12-31193.00M shares
10-Q · filed 2018-02-09
2017-09-30193.00M shares
10-Q · filed 2017-11-14
2017-06-30193.00M shares
10-K · filed 2018-09-26
2017-03-31193.00M shares
10-Q · filed 2017-05-10
2016-12-31193.00M shares
10-Q · filed 2017-02-09
2016-09-30193.00M shares
10-Q · filed 2016-11-09
2016-06-30193.00M shares
10-K · filed 2017-09-28
2016-03-31193.00M shares
10-Q · filed 2016-05-10
2015-12-31193.00M shares
10-Q · filed 2016-02-09
2015-09-30193.00M shares
10-Q · filed 2015-11-09
2015-06-30193.00M shares
10-K · filed 2016-09-09
2015-03-31193.00M shares
10-Q · filed 2015-05-15
2014-12-31193.00M shares
10-Q · filed 2015-02-17
2014-09-30193.00M shares
10-Q · filed 2014-11-14
2014-06-30193.00M shares
10-K · filed 2015-09-14
2014-03-31193.00M shares
10-Q · filed 2014-05-15
2013-12-31193.00M shares
10-Q · filed 2014-02-14
2013-09-30193.00M shares
10-Q · filed 2013-11-14
2013-06-30193.00M shares
10-K · filed 2014-09-29
2013-03-31193.00M shares
10-Q · filed 2013-05-15
2012-12-31193.00M shares
10-Q · filed 2013-02-14
2012-09-30193.00M shares
10-Q · filed 2012-11-14
2012-06-30193.00M shares
10-K · filed 2013-09-30
2012-03-31193.00M shares
10-Q · filed 2012-05-15
2011-12-31193.00M shares
10-Q · filed 2012-02-14
2011-09-30193.00M shares
10-Q/A · filed 2011-12-13
2011-06-30193.00M shares
10-K/A · filed 2012-10-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58